Apr.06.2022
Management / Finance

Notice regarding Partial Amendments to the Retirement of Treasury Shares

PDF(185 KB)

(Retirement of treasury shares pursuant to the provisions of Article 178 of the Companies Act)

　Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “the Company”) had resolved on November 26, 2021 to retire treasury shares pursuant to the provisions of Article 178 of the Companies Act, in accordance with Article 370 (a resolution in writing in place of a Board meeting resolution) of the Companies Act. However, the Company today announced that it has resolved at the meeting of Board of Directors held today to make partial amendments to the contents of the resolution, as follows:

Particulars

　Details of matters and amendments relating to the retirement of treasury shares

  Before amendments After amendments
(Changes are underlined)
Class of shares to be retired Common stocks of the Company Common stocks of the Company
Number of shares to be retired All shares acquired by a resolution in writing in place of a Board meeting resolution held on November 26, 2021 10,916,200 shares
Scheduled date of retirement June 30, 2022 April 28, 2022

(Reference)

  1. Resolution contents regarding the acquisition of treasury shares (resolution in writing in place of a Board meeting resolution held on November 26, 2021)
    1. Class of shares to be acquired Common stocks of the Company
    2. Total number of shares
    that can be acquired    		 11 million shares (maximum)
    (2.20% of the total outstanding shares excluding own shares)
    3. Total amount of
    acquisition cost    		 ¥30 billion yen (maximum)
    4. Period of acquisition November 29, 2021 to April 28, 2022
    5. Method for acquisition Purchase on the Tokyo Stock Exchange
  2. Total number of treasury shares acquired based on the above resolution
    1. Total number of shares acquired 10,916,200 shares
    2. Total amount of
    acquisition cost    		 ¥29,999,828,500
    3. Period of acquisition November 29, 2021 to February 25, 2022 (based on the dates of contracts being executed)
  3. Resolution contents regarding the retirement of treasury shares (resolution in writing in place of a Board meeting resolution held on November 26, 2021)
    1. Class of shares to be retired Common shares of the Company
    2. Number of shares to be retired Total number of treasury shares acquired based on the above item1
    3. Scheduled date of retirement June 30, 2022
  4. The total number of issued shares of the Company after the retirement will be 517,425,200 shares.
Back to List